Small-Molecule Tyrosinase Inhibitors for Treatment of Hyperpigmentation

Molecules. 2025 Feb 8;30(4):788. doi: 10.3390/molecules30040788.

Abstract

Increasing attention is being focused on skin health currently, especially the excessive deposition of melanin in the skin. Tyrosinase, the rate-limiting enzyme in melanin biosynthesis, is a crucial enzyme in melanin synthesis. However, existing tyrosinase inhibitors pose some degree of toxicity to humans. Therefore, the development of more efficient and low-toxicity tyrosinase inhibitors is urgently needed. This review briefly depicts the melanin biosynthesis process and the crystal structure and catalytic mechanism of tyrosinase. The latest research progress regarding small-molecule tyrosinase inhibitors is also reviewed. Moreover, the structure-function relationships are analyzed and summarized. This is expected to provide new and more scientific insights to enable researchers to explore safer and more potent tyrosinase inhibitors.

Keywords: hyperpigmentation; melanin; structure–function relationships (SARs); tyrosinase inhibitor.

Publication types

  • Review

MeSH terms

  • Animals
  • Enzyme Inhibitors* / chemistry
  • Enzyme Inhibitors* / pharmacology
  • Enzyme Inhibitors* / therapeutic use
  • Humans
  • Hyperpigmentation* / drug therapy
  • Melanins* / antagonists & inhibitors
  • Melanins* / biosynthesis
  • Monophenol Monooxygenase* / antagonists & inhibitors
  • Monophenol Monooxygenase* / chemistry
  • Monophenol Monooxygenase* / metabolism
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / pharmacology
  • Structure-Activity Relationship

Substances

  • Monophenol Monooxygenase
  • Enzyme Inhibitors
  • Melanins
  • Small Molecule Libraries